Amerikanische Gesellschaft für Hirudotherapie

External Thrombosed Hemorrhoid (Acute, <72h)

Investigational adjunct for acute external thrombosed hemorrhoids presenting within 72 hours; distinct from internal hemorrhoidal disease.

Tier C — InvestigationalInvestigativLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?
Not FDA-cleared for thrombosed external hemorrhoids. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
Welche Evidenz existiert?
Tier C (investigational). One small uncontrolled case series describes pain reduction; there are no randomized controlled trials. Evidence-based options within 72 hours of symptom onset include surgical excision under local anesthesia (provides the fastest pain relief and definitive thrombus removal — the highest-evidence option), and conservative management with warm sitz baths, topical analgesics (lidocaine), oral analgesics, fiber, and stool softeners for symptoms peaking and resolving over 7 to 14 days.
Hauptrisiken
  • Bleeding from bite sites for 6 to 24 hours after detachment, in a highly vascular and contaminated perianal area
  • Local skin infection or, rarely, Aeromonas infection in a high-bacterial-load area
  • Allergic reaction to leech saliva (uncommon)
  • Severe perianal pain and tenderness for 5 to 10 days
  • Worsening of the thrombosed hemorrhoid pain in the first 24 hours
  • Damage to anal sphincter if placement is improper (NEVER intra-anal)
  • Delay of surgical excision (the fastest pain-relief option within 72 hours)
  • Failure to address strangulated or gangrenous hemorrhoids that require emergent surgery
Wer dies nicht in Betracht ziehen sollte
  • Patients with strangulated or gangrenous thrombosed hemorrhoid (emergent surgical indication)
  • Patients with active perianal abscess or fistula
  • Patients with inflammatory bowel disease and active proctitis
  • Patients beyond the 72-hour window (natural resolution is beginning)
  • Patients on anticoagulants, with hemophilia, or with severe anemia
  • Patients with active genital or perianal infection
  • Pregnant patients (relative contraindication)
Was Sie Ihren Kliniker fragen sollten
  • Has my external thrombosed hemorrhoid been examined to rule out strangulation, gangrene, or abscess?
  • Am I within the 72-hour window where surgical excision provides the fastest relief?
  • If conservative, do I have an adequate plan (sitz baths, topical lidocaine, stool softeners, fiber)?
  • Where exactly will leeches be placed — on perianal skin, NEVER intra-anal or on the thrombus itself?
  • What is the practitioner's experience with perianal anatomy and Aeromonas prevention?
  • What is the bleeding-control plan if a perianal site continues to bleed?
  • What is my long-term hemorrhoidal-disease prevention plan?
Wann dringende medizinische Versorgung suchen
  • Severe worsening perianal pain, fever, or red, hot perianal area (possible abscess — surgical emergency)
  • Inability to urinate or defecate after the session
  • Bleeding that does not stop with firm pressure or bleeding through padding hourly
  • Spreading redness, pus, or red streaks (cellulitis or perirectal infection)
  • Fever above 38.0 C / 100.4 F or chills
  • Skin discoloration, blackening, or necrosis of the hemorrhoid
  • Hives, throat tightness, or breathing difficulty

Was dies NICHT bedeutet

  • This is not FDA-cleared for thrombosed external hemorrhoids.
  • A single small case series does NOT establish efficacy versus surgical excision within 72 hours.
  • Mechanism rationale (local decongestion) does NOT establish clinical equivalence to surgical excision or conservative care.
  • Leech therapy is NEVER intra-anal — that placement risk is unacceptable.
  • Leech therapy is not a substitute for surgical excision in the 72-hour window or emergent surgery for strangulated / gangrenous hemorrhoids.

Clinical Profile

Category
gastrointestinal
ICD-10
K64.5
Safety tier
medium

Evidence Summary

Acute external thrombosed hemorrhoids cause severe perianal pain peaking at 48-72 hours. Surgical excision within 72 hours of onset provides faster pain relief than conservative management (sitz baths, topical analgesics, fiber). No dedicated controlled trial or case series of leech therapy for thrombosed external hemorrhoids has been published; use for this indication is investigational only. If considered at all, leech application would be placed on peripheral perianal skin, never on the thrombus itself and never intra-anally. This is a distinct entity from the registry's grade II-III internal hemorrhoid entry.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Mohsin M et al. (2021), n=14

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Strangulated or gangrenous thrombosed hemorrhoid (emergent surgical)
  • Active perianal abscess or fistula
  • Inflammatory bowel disease with active proctitis
  • Onset >72 hours (natural resolution beginning; risk-benefit unfavorable)

Related Conditions

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.

External Thrombosed Hemorrhoid (Acute, <72h) — Hirudotherapy Evidence | ASH